Morning Read: Utility score helps doctors decide if a chest scan is the best choice

A decision support system that assigns a utility score to orders for chest CT scans has helped doctors decide which patients really needed the scan. The study of 93,818 chest CT exams found that 87% of exams with a high utility score had a positive finding, compared to only 12% of exams with a low utility score.

A venture group and an incubator have offered to help Merck KGaA employees create new startups when the pharma company closes its offices in Geneva. Index Ventures and Eclosion are ready to coach people with new business ideas and help workers find jobs with other biotech firms in Europe.

The Veterans Administration is going to start using its new iPhone electronic health records application this summer at its Washington DC medical centerThe VA will launch the app once a stronger mobile device manager is in place.

A Boston biotech company has added $4 million to a previously disclosed debt round to support its unique delivery system for cancer drugs. Mersana uses a polymer to deliver drugs directly to cancer cells without affecting healthy cells.


Forbes parses the impact of the CATT study for Regeneron Pharmaceuticals.  The study compared Avastin and Lucentis for treating wet advanced macular degeneration and found they were equally effective. Analysts say the upshot is a slight edge to Eylea because it can be dosed every other month, yet has shown to be as effective as Lucentis which is given monthly.

Veronica Combs

I was the editor in chief at I started writing and editing in the print world and joined a dotcom right before the 2000 crash. I was at TechRepublic/CNET/BNET for 7 years. Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news. A year later, MedTrackAlert was acquired by HealthCentral, so I shifted to audience research. The fun of daily news and interviewing smart people brought me to MedCity News in February 2012. More posts by Author

No comments